Asset-Light Expansion Into $8B German Market Adds Potential To This Cannabis Stock On NASDAQ

By Nicolás Jose Rodriguez

The potential rescheduling of cannabis in the U.S. and the growing demand in Germany positions InterCure (NASDAQ: INCR ), the leading seller of pharmaceutical cannabis outside North America, to capitalize on these opportunities, according to a recent initi

You are viewing a robot-friendly page.Click hereto reload in standard format.